Back to search

Article

HER2 Amplification and PD-L1 Expression in Advanced Gastric Cancer: Correlations, Clinical Implications, and Molecular Characteristics

2024-08-19

Abstract excerpt

<title>Abstract</title> <p>Epidermal growth factor receptor 2 (<italic>HER2</italic>) and programmed cell death ligand 1 (PD-L1) are pivotal therapeutic targets in advanced gastric cancer (GC). Nevertheless, the correlation between them, along with the clinical and genomic characteristics, and prognosis differences across distinct molecular subtypes, remains elusive. In this retrospective study, 390 advanced GC p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
69426854-844e-544c-b7ab-e63808107015
DOI
10.21203/rs.3.rs-4209264/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
HER2 Amplification and PD-L1 Expression in Advanced Gastric Cancer: Correlations, Clinical Implications, and Molecular CharacteristicsDOI 10.21203/rs.3.rs-4209264/v1
Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies.Semantic proximity
The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD-L1 expression.Semantic proximity
Genomic correlations for clinical outcomes in HER2-positive advanced gastric cancers treated using trastuzumab-based therapySemantic proximity
Real-World Genomic Landscape of Korean Gastric Cancer: Integrating Biomarker Associations and Clinical Outcomes in Metastatic Gastric Cancer.Semantic proximity
Immunohistochemical‐Based Molecular Typing of ACRG Combined With Immune‐Associated PD ‐ L1 Expression Can Predict the Prognosis of Gastric CancerSemantic proximity
First-line pembrolizumab, trastuzumab, and chemotherapy in advanced HER2-positive gastric cancer with sequential genomic profilingSemantic proximity
Mutations Defining Patient Cohorts With Elevated PD-L1 Expression in Gastric CancerSemantic proximity
What’s New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future PerspectivesSemantic proximity
Molecular characteristics of gastric cancer with ERBB2 amplificationSemantic proximity
Development and Validation of an Easy-to-Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic ImplicationsSemantic proximity
Chilean Gastric Cancer Task Force: A study protocol to obtain a clinical and molecular classification of a cohort of gastric cancer patients.Semantic proximity
Comprehensive molecular characterization of gastric adenocarcinoma.Semantic proximity
Select a neighboring publication to make it the new centre.